52
Views
25
CrossRef citations to date
0
Altmetric
Original Paper

Investigation of Burkholderia cepacia Nosocomial Outbreak with High Fatality in Patients Suffering from Diseases other than Cystic Fibrosis

, , , , , & show all
Pages 174-178 | Received 16 Oct 2003, Accepted 20 Jan 2004, Published online: 08 Jul 2009

  • Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8: 181–7.
  • Speert DP. Advances in Burkholderia cepacia complex. Paediatr Respir Rev 2002; 3: 230–5.
  • Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001; 33: 1469–5.
  • Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Quiymi S, Johnson JA, Li Puma JJ, et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 2001; 22: 419–22.
  • Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2000; 39: 2891–6.
  • McDowell A, Mahenthiralingam E, Moor JE, Dunbar KEA, Webb AK, Dodd ME, et al. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J Clin Microbiol 2001; 39: 4247–55.
  • Bevivino A, Dalmastri C, Tabacchioni S, Chiarini L, Belli ML. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2000; 2002; 40: 486–51.
  • Jones AM, Dodd ME, Webb AK. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas. Eur Respr J 2001; 17: 295–301.
  • Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang RZ, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999; 179: 1197–205.
  • LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pul Med 1998; 4: 337–41.
  • Yu WL, Wang DY, Lin CW, Tsou MF. Endemic Burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis 1999; 31: 293–8.
  • Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnnauwakul S. An outbreak of Burkholderia cepacia bacteraemia in haemodialysis patients: an epidemiological and molecular study. Am J Kidney Dis 2000; 36: 199–204.
  • Lu DC, Chang SC, Chen YC, Luh KT, Hsieh WC. In vitro activities of antimicrobial agents, alone and in combination against Burkholderia cepacia isolated from blood. Diag Microbiol Infect Dis 1997; 28: 187–91.
  • Garner JS, Javis WR, Emori TG, Horan TC, Hughes JM, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
  • National Committee for Clinical Standards (NCCLS). 1997. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A6. Committee for Clinical Standards, Wayne, PA., USA.
  • Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38: 3165–73.
  • Okazaki M, Watanabe T, Morita K, Higurashi Y, Araki K, Shukuya N, et al. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks. J Clin Microbiol 1999; 37: 3809–14.
  • Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M. Use of the E-test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2003; 22(1): 28–34.
  • Saika T, Kobayashi I, Hasegawa M, Nishida M. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates. J Infect Chemother 2002; 8: 341–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.